Literature DB >> 12770793

Mannose binding lectin gene polymorphism in patients with type I diabetes.

Akito Tsutsumi1, Hiroshi Ikegami, Reiko Takahashi, Hideyuki Murata, Daisuke Goto, Isao Matsumoto, Tomomi Fujisawa, Takayuki Sumida.   

Abstract

Our purpose was to investigate a possible relationship between occurrence of type I diabetes and polymorphism of the mannose binding lectin gene. Polymorphism of codon 54 of the mannose binding lectin (MBL) gene, whose presence of the minority allele leads to significant reduction of serum MBL concentration, was investigated in 128 Japanese patients with type I diabetes and 78 healthy volunteers by restriction fragment length polymorphism method. Frequencies of the minority allele were compared between the patient group and the control group. Frequency of the minority allele was 24.2% in the patient group and 19.9% in the control group. The probability of being heterozygous or homozygous for the minority allele was 41.4% in the patient group and 33.3% in the control group. Patients with DRB1*0405-DQB1*0401 and/or DRB1*0901-DQB1*0303 haplotypes, the two major type I diabetes-prone human leukocyte antigen haplotypes, showed a slightly higher probability of being heterozygous or homozygous for allele B of the MBL gene. Possession of the minority allele of the MBL gene may be a minor risk factor for having type I diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770793     DOI: 10.1016/s0198-8859(03)00054-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Elevated Serum Mannose-Binding Lectin Levels Are Associated with Poor Outcome After Acute Ischemic Stroke in Patients with Type 2 Diabetes.

Authors:  Fang-Yu Song; Meng-Hai Wu; Li-Hua Zhu; Zhi-Qiang Zhang; Qin-De Qi; Chang-Li Lou
Journal:  Mol Neurobiol       Date:  2014-10-25       Impact factor: 5.590

2.  Polymorphism in ficolin-1 (FCN1) gene is associated with an earlier onset of type 1 diabetes mellitus in children and adolescents from northeast Brazil.

Authors:  Zilma Pereira Dos Anjosa; Manuella Maria Silva Santos; Natassia Javorski Rodrigues; Glaucia Alyne Nunes De Lacerda; Jaqueline Araujo; Jaqueline De Azevêdo Silva; Nathália De Alencar Cunha Tavares; Rafael Lima Guimarães; Sergio Crovella; Lucas André Cavalcanti Brandão
Journal:  J Genet       Date:  2016-12       Impact factor: 1.166

3.  Association between complement gene polymorphisms and systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Hamidreza Ebrahimiyan; Shayan Mostafaei; Saeed Aslani; Seyedeh Tahereh Faezi; Elham Farhadi; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Clin Exp Med       Date:  2021-09-14       Impact factor: 5.057

4.  Dendritic cell-based assays, but not mannosylation of antigen, improves detection of T-cell responses to proinsulin in type 1 diabetes.

Authors:  Parth Narendran; Kathryn Elsegood; Nicola J Leech; Wallace M Macindoe; Geert-Jan Boons; Colin M Dayan
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

5.  The relationship between serum mannose-binding lectin levels and acute ischemic stroke risk.

Authors:  Zhen-Yu Wang; Zhong-Ren Sun; Li-Ming Zhang
Journal:  Neurochem Res       Date:  2013-12-06       Impact factor: 3.996

6.  Elevated MBL concentrations are not an indication of association between the MBL2 gene and type 1 diabetes or diabetic nephropathy.

Authors:  Mari A Kaunisto; Lisa Sjölind; Riitta Sallinen; Kim Pettersson-Fernholm; Markku Saraheimo; Sara Fröjdö; Carol Forsblom; Johan Fagerudd; Troels K Hansen; Allan Flyvbjerg; Maija Wessman; Per-Henrik Groop
Journal:  Diabetes       Date:  2009-04-14       Impact factor: 9.461

7.  Association of levels of mannose-binding lectin and the MBL2 gene with type 2 diabetes and diabetic nephropathy.

Authors:  Nana Zhang; Maoqiang Zhuang; Aixia Ma; Guochang Wang; Ping Cheng; Yajun Yang; Xiaofeng Wang; Juan Zhang; Xingdong Chen; Ming Lu
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.